EAM
BSX icon

Exome Asset Management’s Boston Scientific BSX Stock Holding History

Exome Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.03M Buy
+48,347
New +$3.87M 1.57% 24
2025
Q1 		– Sell
-40,500
Closed -$3.62M – 66
2024
Q4 		$3.62M Buy
+40,500
New +$3.57M 2.72% 14

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Exome Asset Management's BSX Position: Q1 2026 in Review

Exome Asset Management opened a new position in Boston Scientific (BSX) in Q1 2026: 48,347 shares worth $3.03M. The stake represents 1.57% of the portfolio and ranks #24 among its holdings. This is a return to the name: Exome Asset Management previously reported a position in BSX as recently as Q4 2024.

Exome Asset Management first reported a position in BSX in Q4 2024 and has held it in 2 quarters since. The position peaked at $3.62M in Q4 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Exome Asset Management held 48,347 shares of Boston Scientific worth $3.03M as of Q1 2026.
  • Boston Scientific was a new Exome Asset Management position in Q1 2026.
  • Boston Scientific made up 1.57% of Exome Asset Management's portfolio in Q1 2026, its #24 holding.
  • Exome Asset Management first reported a position in Boston Scientific in Q4 2024 and has held it in 2 quarters since.
  • Exome Asset Management's Boston Scientific position peaked at $3.62M in Q4 2024.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Exome Asset Management's 13F filing for Q1 2026, filed 15 May 2026.